Clinical Trial Update: Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of toripalimab in HER2-negative metastatic breast cancer patients treated with metronomic vinorelbine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Toripalimab (Toripalimab)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN